The Immune System’s Redesigned Role in Fighting Cancerous Tumors

A Novel Combination of Two Agents Eradicates Solid Tumors in Preclinical Studies March 11, 2014 Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute eradicated solid tumors in laboratory mice using a novel combination of two targeted agents. These two synergistic therapies stimulate an immune response, ultimately allowing solid tumors to act as their own cancer-fighting vaccine. The study’s findings, published in …

Kidney Cancer Care Improves With Vaccine-Based Approach

February 18, 2014 The Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute has opened a novel Phase III, vaccine-based clinical trial aimed at providing kidney cancer patients long-term control of their disease. Survival outcomes for patients with renal cell carcinoma, the most common form of kidney cancer, have improved significantly over the past decade due to research advances in personalized or “targeted” therapies designed to target …